Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non–Small Cell Lung Cancer
Ila Datar(Yale University), Kurt A. Schalper(Yale Cancer Center)
Cited by 36
Related Papers
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
|Journal for ImmunoTherapy of Cancer|2019|195
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
|Nature Communications|2018|189
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer
|Journal for ImmunoTherapy of Cancer|2022|123
Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer
|Journal for ImmunoTherapy of Cancer|2022|9